AIDS risk-reduction guidelines: a review and analysis. NLM AIDSLINE Important note: Information in this article was accurate in 1987. The state of the art may have changed since the publication date.

Click here to return to AIDSLINE main menu
DonateNow
Print this Article


AIDS risk-reduction guidelines: a review and analysis.

J Community Health. 1986 Winter;11(4):233-43. Unique Identifier : AIDSLINE MED/87166856
Siegel K; Grodsky PB; Herman A

Abstract: Until an effective treatment or vaccine for AIDS is developed, the principal strategy for controlling its spread will remain persuading at-risk and diseased populations to modify behaviors implicated in the transmission of the disease. In the case of homosexual and bisexual men the risk-reduction or safe-sex brochure has emerged as the most widely used public health intervention modality. While there has been a proliferation of such brochures, to date no systematic analysis of the content or potential efficacy of these materials has been undertaken. The authors carry out two kinds of analyses of a sample of risk-reduction brochures. First, these materials are characterized in terms of 13 characteristics related to their content, and style. Second, the extent to which they incorporate the elements of a standard model of health communication is assessed. Limitations of existing brochures are identified and the implications of the findings for the development of future materials are discussed.
Keywords: Acquired Immunodeficiency Syndrome/*PREVENTION & CONTROL/ TRANSMISSION Adult *Behavior Therapy Evaluation Studies *Health Education Homosexuality Human Male *Motivation Pamphlets Risk-Taking Safety Sex Behavior Teaching Materials/STANDARDS JOURNAL ARTICLE

KWDacquiredimmunodeficiencysyndrome/KWDprevention&control/transmissionadultKWDbehaviortherapyevaluationstudiesKWDhealtheducationhomosexualityhumanmaleKWDmotivationpamphletsrisk-takingsafetysexbehaviorteachingmaterials/standardsjournalarticle
870730
M8770305

Copyright © 1987 - National Library of Medicine. Reproduced under license with the National Library of Medicine, Bethesda, MD.

AEGiS is a 501(c)3, not-for-profit, tax-exempt, educational corporation. AEGiS is made possible through unrestricted funding from Boehringer Ingelheim, Bridgestone/Firestone Charitable Trust, Bristol-Myers Squibb Company, Elton John AIDS Foundation, Gill Foundation, the National Library of Medicine, Quest Diagnostics, Roche and Trimeris, and donations from users like you. Always watch for outdated information. This article first appeared in 1987. This material is designed to support, not replace, the relationship that exists between you and your doctor.

AEGiS presents published material, reprinted with permission and neither endorses nor opposes any material. All information contained on this website, including information relating to health conditions, products, and treatments, is for informational purposes only. It is often presented in summary or aggregate form. It is not meant to be a substitute for the advice provided by your own physician or other medical professionals. Always discuss treatment options with a doctor who specializes in treating HIV.

Copyright ©1980, 1987. AEGiS. All materials appearing on AEGiS are protected by copyright as a collective work or compilation under U.S. copyright and other laws and are the property of AEGiS, or the party credited as the provider of the content. .